Tesla Inc.'s Model 3 Deliveries Start This Week
For Tesla investors, all eyes are on Tesla's Model 3 launch on Friday.
Schlumberger's Second-Quarter Earnings Rebound Slightly, but Remain in the Loss Column
Global oil and gas activity hasn't fully recovered, but at least it is no longer declining.
Why Big Oil Can’t Make the Renewable Energy Transition
Today's fossil fuel giants can see that wind and solar power will be eating their lunch tomorrow, but knowing the disruption is coming doesn't mean they can pivot to meet it.
3 Cheap High-Yield Dividend Stocks You Can Buy Right Now
If you consider the long term prospects of Enterprise Products Partners, STAG Industrial, and Brookfield Renewable Partners, then their current stock prices look sensible.
Qualcomm's making a big push into the smartphone fingerprint scanning market with a range of technologies.
iPhones and more.
The chip giant is reporting second-quarter results on Thursday night. Here's what you should be looking for in this report.
Here are some of the biggest movers or biggest headlines from this week in the markets.
Giving their growth potential, Latin America's MercadoLibre and China's Alibaba are more attractive long-term holdings than the original online marketplace.
The cast fields listener questions to dig into the outlook for mall-based apparel chain Buckle before exploring the $30 billion private label brand, Kirkland Signature.
Sometimes getting ahead is all about who you know,
If you think the processing of big data will grow in importance, this tech company is worth spending some time with.
First Data's payment processing solutions have lagged competitors' offerings in recent years. Will its acquisition of CardConnect right the ship?
Think 67 is the right age to take your benefits? Here's why you might be wrong.
Novavax announces a major clinical update on July 24. Expect the best but prepare for the worst?
Qualcomm had a lot of good news to share about its chip business.
And the profits Oshkosh will earn are the best part.
The first is the most important, and I truly hope the last never comes true.
The gunsmith makes up in innovation what it lacks in historical significance.
With big biotechs Celgene and Gilead Sciences, it's a battle of growth stock versus income/value stock.
Can Democrats and Republicans actually work together to formulate a new healthcare plan?
OPEC’s production cut compliance continues to drop, is this the end of its attempt to prop up oil prices?
Hawaii continues to push the envelope in renewable energy, providing a path for the rest of the country.
Verizon's unlimited plan is keeping subscribers from switching to T-Mobile.